Your browser is no longer supported. Please, upgrade your browser.
PFE [NYSE]
Pfizer Inc.
IndexS&P 500 P/E19.63 EPS (ttm)2.19 Insider Own0.04% Shs Outstand5.60B Perf Week0.40%
Market Cap239.24B Forward P/E11.31 EPS next Y3.80 Insider Trans-0.32% Shs Float5.59B Perf Month-0.16%
Income12.40B PEG1.58 EPS next Q1.09 Inst Own67.50% Short Float0.97% Perf Quarter0.42%
Sales55.52B P/S4.31 EPS this Y-33.10% Inst Trans0.05% Short Ratio1.70 Perf Half Y11.32%
Book/sh12.51 P/B3.43 EPS next Y-7.68% ROA8.00% Target Price46.72 Perf Year21.14%
Cash/sh3.90 P/C11.03 EPS next 5Y12.42% ROE19.80% 52W Range32.79 - 51.86 Perf YTD16.73%
Dividend1.56 P/FCF19.04 EPS past 5Y2.20% ROI7.60% 52W High-17.14% Beta0.71
Dividend %3.63% Quick Ratio1.10 Sales past 5Y-3.00% Gross Margin74.70% 52W Low31.05% ATR0.78
Employees78500 Current Ratio1.40 Sales Q/Q92.40% Oper. Margin24.30% RSI (14)49.28 Volatility1.69% 1.78%
OptionableYes Debt/Eq0.56 EPS Q/Q111.20% Profit Margin23.80% Rel Volume0.69 Prev Close42.97
ShortableYes LT Debt/Eq0.50 EarningsNov 02 BMO Payout65.10% Avg Volume32.06M Price42.97
Recom2.60 SMA201.31% SMA50-3.44% SMA2007.48% Volume0 Change0.00%
Jul-27-21Resumed Truist Buy $43
May-06-21Downgrade Mizuho Buy → Neutral $42
Apr-07-21Resumed RBC Capital Mkts Sector Perform $42
Feb-04-21Upgrade DZ Bank Hold → Buy $41
Dec-16-20Downgrade RBC Capital Mkts Outperform → Sector Perform $43 → $42
Nov-19-20Resumed Goldman Neutral $40
Nov-10-20Resumed Bernstein Mkt Perform $42
Oct-12-20Downgrade Atlantic Equities Overweight → Neutral $44 → $39
Sep-29-20Initiated Berenberg Hold $38
Jun-16-20Initiated SVB Leerink Mkt Perform $40
Feb-27-20Upgrade Standpoint Research Hold → Buy
Feb-27-20Initiated Barclays Equal Weight $36
Feb-06-20Initiated Mizuho Buy
Jan-07-20Initiated RBC Capital Mkts Outperform $46
Oct-17-19Resumed BofA/Merrill Neutral $37
Jul-30-19Downgrade Morgan Stanley Overweight → Equal-Weight $48 → $40
Jul-30-19Downgrade BofA/Merrill Buy → Neutral
Jun-04-19Resumed Morgan Stanley Overweight $48
Feb-20-19Resumed Citigroup Neutral $41
Jan-31-19Upgrade Credit Suisse Neutral → Outperform
Oct-28-21 07:33AM  
07:27AM  
06:45AM  
06:10AM  
06:04AM  
Oct-27-21 04:45PM  
04:10PM  
03:49PM  
02:58PM  
01:45PM  
11:18AM  
11:10AM  
11:00AM  
10:46AM  
10:00AM  
09:28AM  
07:37AM  
06:28AM  
04:49AM  
Oct-26-21 10:01PM  
07:09PM  
06:23PM  
06:13PM  
05:45PM  
05:34PM  
05:32PM  
05:20PM  
05:15PM  
05:14PM  
05:03PM  
04:24PM  
03:02PM  
12:30PM  
09:50AM  
08:03AM  
07:00AM  
07:00AM  
06:41AM  
06:30AM  
05:52AM  
12:01AM  
Oct-25-21 04:30PM  
12:55PM  
12:41PM  
12:22PM  
12:09PM  
12:04PM  
12:02PM  
11:52AM  
11:48AM  
10:58AM  
10:41AM  
10:17AM  
08:56AM  
08:52AM  
08:50AM  
08:20AM  
08:09AM  
06:00AM  
05:08AM  
Oct-24-21 04:01PM  
03:32PM  
Oct-23-21 03:06PM  
Oct-22-21 10:05PM  
06:48PM  
06:37PM  
05:02PM  
05:01PM  
04:15PM  
03:48PM  
03:32PM  
03:01PM  
02:22PM  
12:07PM  
10:54AM  
10:43AM  
10:32AM  
10:25AM  
10:08AM  
10:06AM  
10:01AM  
09:46AM  
09:05AM  
08:42AM  
08:30AM  
08:17AM  
07:48AM  
05:51AM  
Oct-21-21 09:05PM  
07:48PM  
06:12PM  
04:08PM  
04:03PM  
03:50PM  
03:36PM  
01:35PM  
01:31PM  
11:39AM  
11:27AM  
11:15AM  
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and pain under the Eliquis, Chantix/Champix, and Premarin family brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zithromax, Vfend, and Panzyga brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Prevnar 13/Prevenar 13 (pediatric/adult), Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Pfizer-BioNTech COVID-19 vaccine brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, and Eucrisa/Staquis brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Syapse, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DAMICO JENNIFER B.SVP & ControllerAug 13Sale48.301,66180,2269,769Aug 16 08:12 PM
DAMICO JENNIFER B.SVP & ControllerJul 30Sale42.862,500107,15011,430Aug 02 07:02 PM
DAMICO JENNIFER B.SVP & ControllerMay 05Sale40.822,500102,05013,748May 07 04:10 PM
MACKENZIE ALEXANDER RExecutive Vice PresidentFeb 27Option Exercise22.3529,838666,879153,338Mar 02 05:59 PM
JOHNSON RADY AExecutive Vice PresidentFeb 27Option Exercise22.3525,165562,43895,309Mar 02 05:59 PM
SUSMAN SALLYExecutive Vice PresidentFeb 27Option Exercise22.3571,8991,606,943193,474Mar 02 05:59 PM
YOUNG JOHN DGroup PresidentFeb 27Option Exercise22.35129,4192,892,515575,282Mar 02 05:59 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 27Option Exercise22.3553,9251,205,224150,172Mar 02 06:00 PM
BOURLA ALBERTChairman & CEOFeb 27Option Exercise22.3553,9251,205,224165,034Mar 02 05:34 PM
Carapezzi William R JRExecutive Vice PresidentFeb 27Option Exercise22.3521,570482,09072,522Mar 02 05:35 PM
DAMICO JENNIFER B.SVP & ControllerFeb 27Option Exercise22.359,886220,95223,745Mar 02 05:35 PM
DAMELIO FRANK AExecutive Vice PresidentFeb 27Option Exercise22.35152,7853,414,745607,441Mar 02 05:35 PM
Hwang AngelaGroup PresidentFeb 27Option Exercise22.359,886220,95234,211Mar 02 05:35 PM
SAHNI PAYALExecutive Vice PresidentFeb 25Option Exercise22.899,982228,48822,949Mar 01 04:10 PM
YOUNG JOHN DGroup PresidentFeb 25Option Exercise22.89163,3343,738,715579,791Mar 01 04:10 PM
SUSMAN SALLYExecutive Vice PresidentFeb 25Option Exercise22.8981,6671,869,358189,763Mar 01 04:10 PM
JOHNSON RADY AExecutive Vice PresidentFeb 25Option Exercise22.8937,658861,992100,937Mar 01 04:05 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 25Option Exercise22.8999,8162,284,788178,092Mar 01 04:05 PM
Hwang AngelaGroup PresidentFeb 25Option Exercise22.8922,686519,28342,927Mar 01 04:01 PM
BOURLA ALBERTChairman & CEOFeb 25Option Exercise22.86163,3343,733,815245,037Mar 01 03:58 PM
Carapezzi William R JRExecutive Vice PresidentFeb 25Option Exercise22.8927,222623,11271,553Mar 01 03:58 PM
DAMELIO FRANK AExecutive Vice PresidentFeb 25Option Exercise22.89163,3343,738,715588,584Mar 01 03:58 PM
DAMICO JENNIFER B.SVP & ControllerFeb 25Option Exercise22.8912,477285,59919,781Mar 01 03:55 PM
BOURLA ALBERTChairman & CEONov 09Sale41.94132,5085,557,38678,273Nov 10 05:55 PM
SUSMAN SALLYExecutive Vice PresidentNov 09Sale41.9443,6621,831,184108,096Nov 10 05:55 PM